DPH.L
Price:
$3866
Market Cap:
$4.40B
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, su...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2000-09-21
Stock Exchange
LSE
Ticker
DPH.L
According to Dechra Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current PE Ratio is -154.64. This represents a change of -1121.92% compared to the average of 15.13 of the last 4 quarters.
The mean historical PE Ratio of Dechra Pharmaceuticals PLC over the last ten years is 45.15. The current -154.64 PE Ratio has changed -34346.56% with respect to the historical average. Over the past ten years (40 quarters), DPH.L's PE Ratio was at its highest in in the March 2022 quarter at 126.41. The PE Ratio was at its lowest in in the June 2023 quarter at -41.55.
Average
45.15
Median
69.93
Minimum
-150.74
Maximum
91.59
Discovering the peaks and valleys of Dechra Pharmaceuticals PLC PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 314.66%
Maximum Annual PE Ratio = 91.59
Minimum Annual Increase = -332.78%
Minimum Annual PE Ratio = -150.74
Year | PE Ratio | Change |
---|---|---|
2023 | -150.74 | -332.78% |
2022 | 64.76 | -24.38% |
2021 | 85.63 | -1.44% |
2020 | 86.88 | -5.15% |
2019 | 91.59 | 21.96% |
2018 | 75.10 | 24.05% |
2017 | 60.54 | -26.79% |
2016 | 82.69 | 86.25% |
2015 | 44.40 | 314.66% |
2014 | 10.71 | -69.02% |
The current PE Ratio of Dechra Pharmaceuticals PLC (DPH.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.12
5-year avg
35.62
10-year avg
45.15
Dechra Pharmaceuticals PLC’s PE Ratio is less than Diploma PLC (49.65), less than Genus plc (169.22), less than Hikma Pharmaceuticals PLC (18.74), less than Cranswick plc (24.16), less than Croda International Plc (31.92),
Company | PE Ratio | Market cap |
---|---|---|
49.65 | $5.76B | |
169.22 | $1.34B | |
18.74 | $4.08B | |
24.16 | $2.72B | |
31.92 | $5.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dechra Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dechra Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Dechra Pharmaceuticals PLC's PE Ratio?
How is the PE Ratio calculated for Dechra Pharmaceuticals PLC (DPH.L)?
What is the highest PE Ratio for Dechra Pharmaceuticals PLC (DPH.L)?
What is the 3-year average PE Ratio for Dechra Pharmaceuticals PLC (DPH.L)?
What is the 5-year average PE Ratio for Dechra Pharmaceuticals PLC (DPH.L)?
How does the current PE Ratio for Dechra Pharmaceuticals PLC (DPH.L) compare to its historical average?